tradingkey.logo

Cytosorbents Corp <CTSO.OQ> expected to post a loss of 6 cents a share - Earnings Preview

ReutersMar 4, 2025 9:26 PM
  • Cytosorbents Corp CTSO.OQ CTSO.O is expected to show a rise in quarterly revenue when it reports results on March 6 for the period ending December 31 2024

  • The Princeton New Jersey-based company is expected to report a 16.5% increase in revenue to $10.1 million from $8.67 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Cytosorbents Corp is for a loss of 6 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Cytosorbents Corp is $7.00​, above​ its last closing price of $1.03. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.06

-0.06

-0.04

Beat

36.8

Jun. 30 2024

-0.09

-0.10

-0.08

Beat

17.9

Mar. 31 2024

-0.12

-0.12

-0.12

Met

0​

Dec. 31 2023

-0.10

-0.14

-0.13

Beat

5.5

​​Sep. 30 2023

-0.15

-0.14

-0.21

Missed

-52.2

Jun. 30 2023

-0.11

-0.11

-0.14

Missed

-24.4​

Mar. 31 2023

-0.13

-0.13

-0.17

Missed

-34.2

Dec. 31 2022

-0.18

-0.17

-0.02

Beat

88.1

This summary was machine generated March 4 at 21:26 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI